Fighting Fatigue in Systemic Lupus Erythematosus: Experience of Dehydroepiandrosterone on Clinical Parameters and Patient-Reported Outcomes

Manifestations related to ongoing inflammation in systemic lupus erythematosus (SLE) are often adequately managed, but patient-reported outcome measures (PROMs) support that fatigue and low quality of life (QoL) in the absence of raised disease activity remain major burdens. The adrenal hormone dehy...

Descripción completa

Detalles Bibliográficos
Autores principales: Skoglund, Oliver, Walhelm, Tomas, Thyberg, Ingrid, Eriksson, Per, Sjöwall, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505355/
https://www.ncbi.nlm.nih.gov/pubmed/36142945
http://dx.doi.org/10.3390/jcm11185300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505355/
https://www.ncbi.nlm.nih.gov/pubmed/36142945
http://dx.doi.org/10.3390/jcm11185300

Ejemplares similares